Skip to main content
. 2016 Jul 14;13:E90. doi: 10.5888/pcd13.160078

Figure 2.

Figure 2

Changes in the use of antithrombotic therapy, by type of therapy and by patient groups (intervention arm and control arm), in a cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool in a sample of general practices in New South Wales, Australia, 2012–2013. Percentages may not total 100 because of rounding.

Therapy Number of Patients (Proportion of Patients by Intervention Group and Control Group)
Intervention Group: Baseline Therapy Intervention Group: Post-CARAT Therapy Intervention Group: CARAT-Recommended Therapy Control Group
Warfarin (± antiplatelet) 154 (74.8) 156 (75.7) 168 (81.6) 162 (86.6)
Aspirin only 17 (8.3) 14 (6.8) 38 (18.4) 6 (3.2)
Clopidogrel only 3 (1.5) 0 (0.0) 0 (0.0) 0 (0.0)
Dabigatran (± clopidogrel) 30 (14.6) 34 (16.5) 0 (0.0) 15 (8.0)
None 2 (1.0) 2 (1.0) 0 (0.0) 4 (2.1)
Total 206 (100.2) 206 (100.0) 206 (100.0) 187 (99.9)